Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma

Modern Pathology

Volumn 9, Issue 7, 1996, Pages 725-730

  Frierson Jr , Henry F ^a   Gaffey, Michael J ^a   Zukerberg, Lawrence R ^b   Arnold, Andrew ^b   Williams, Michael E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Chromosome 11q13; Cyclin D1; Histologic grade

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; CYCLINS; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; ONCOGENE PROTEINS;

EID: 8944260417     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707, 1994
2. 1. Genes Dev 7:812, 1993
3. 1 phase in rodent fibroblasts. Genes Dev 7:1559, 1993
4. Dowdy SF, Hinds PW, Louie K, et al.: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499, 1993
5. Rosenberg CL, Wong E, Petty EM, et al.: PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 88:9638, 1991
6. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A: Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7:241, 1993
7. Arnold A, Kim HG, Gaz RD, et al.: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034, 1989
8. Rosenberg CL, Motokura T, Kronenberg HM, Arnold A: Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene 8:519, 1993
9. Fantl V, Richards MA, Smith R, et al.: Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 26:423, 1990
10. Lammie GA, Fantl V, Smith R, et al.: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439, 1991
11. Theillet C, Adnane J, Szepetowski P, et al.: BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 5:147, 1990
12. Buckley MF, Sweeney KJE, Hamilton JA, et al.: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127, 1993
13. Gaffey MJ, Frierson HF Jr, Williams ME: Chromosome 11q13, c-erb-B-2, and c-myc amplification in invasive breast carcinoma: Clinicopathologic correlations. Mod Pathol 6:654, 1993
14. Borg A, Sigurdsson H, Clark GM, et al.: Association of INT2/ HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 63:136, 1991
15. Berns EMJJ, Klijn JGM, van Staveren IL, et al.: Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors. Eur J Cancer 28:697, 1992
16. Adnane J, Gaudray P, Simon M-P, et al.: Proto-oncogene amplification and human breast tumor phenotype. Oncogene 4:1389, 1989
17. Schuuring E, Verhoeven E, van Tinteren H, et al.: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52:5229, 1992
18. Lidereau R, Callahan R, Dickson C, et al.: Amplification of the int-2 gene in primary human breast tumors. Oncogene Res 2:285, 1988
19. Yang W-I, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 (bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86, 1994
20. Swerdlow SH, Yang W-I, Zukerberg LR, et al.: Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 26:999, 1995
21. Zukerberg LR, Yang W-I, Gadd M, et al.: Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8:560, 1995
22. Gaffey MJ, Iezzoni JC, Meredith SD, et al.: Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase π gene expression in head and neck squamous cell carcinoma. Hum Pathol 26: 1221, 1995
23. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histologic grade in breast cancer: Experience from a large study with long-term followup. Histopathology 19:403, 1991
24. Wang TC, Cardiff RD, Zukerberg L, et al.: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669, 1994
25. Williams ME, Innes DJ, Borowitz MJ, et al.: Immunoglobulin and T-cell receptor gene rearrangements in human lymphoma and leukemia. Blood 69:79, 1987
26. Lee JT, Innes DJ, Williams ME: Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest 84: 1454, 1989
27. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A: Characterization of chromosome 11 translocation breakpoints at the bel-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 52(Suppl):5541s, 1992
28. Motokura T, Bloom T, Kim HG, et al.: A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 350:512, 1991
29. Frierson HF Jr, Gaffey MJ, Meredith SD, Boyd JC, Williams ME: Immunohistochemical staining and Southern blot hybridization for glutathione S-transferase π in mammary infiltrating ductal carcinoma. Mod Pathol 8:643, 1995
30. Bartkova J, Lukas J, Strauss M, Bartek J: Cell cycle-related variations and tissue-restricted expression of human cyclin D1 protein. J Pathol 172:237, 1994
31. Gillett C, Fantl V, Smith R, et al.: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812, 1994
32. Bartkova J, Lukas J, Muller H, et al.: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353, 1994
33. Worsley SD, Jennings BA, Khalil KH, Mole M, Girling AC: Cyclin D1 amplification and expression in human breast carcinoma: Correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol Mol Pathol 49:M46,1996
34. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102:695, 1994
35. McIntosh GG, Anderson JJ, Milton I, et al.: Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11:885, 1995
36. Frierson HF Jr: Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: Comparison with clinical and pathologic variables. Mod Pathol 6:290, 1993
37. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A: Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6:499, 1991
38. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 90:1112, 1993